ºÚÁÏÍø

Governor Roy Cooper signed an executive order expanding access to monoclonal antibody treatments that have the potential to prevent people from dying of COVID-19. The emergency-use treatment is used on high-risk COVID-19 patients who experience symptoms within 10 days of testing positive. This treatment is reported to be similar to...

Giselle Corbie-Smith, MD, Kenan Distinguished Professor in the Departments of Medicine and Social Medicine, has received the 2021 McClinton Outstanding Faculty Staff Award. Corbie-Smith is nationally known for her scholarly work on the inclusion of disparity populations in research and has over a decade of experience in using community engagement to...

Newly released Action Briefs now make it easier for employers, insurers, healthcare systems, policy makers, and leaders in other organizations to take specific, practical actions to support their constituents with osteoarthritis. The Osteoarthritis Action Alliance (OAAA), partnering with the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation,...

Researchers with the University of North Carolina at Chapel Hill are looking into a new treatment for COVID-19. Vice chair of the study, Dr. David Wohl, professor of medicine in the division of infectious diseases, says the monoclonal antibody cocktail is able to attach to the virus and prevent it...

A WRAL TechWire report says Brii Biosciences, which has operations in Durham as well as Beijing, has announced its commitment to support a combination therapy called BRII-196/BRII-198. “So far, this therapy and other monoclonal antibodies show effectiveness against the Delta variant, which now accounts for almost all the COVID-19 cases...

As college football stadiums across the nation fill up with cheering fans and limited masking, a Raleigh News & Observer article asks the experts about virus spread. David Wohl, MD, professor of medicine in the division of infectious diseases responded. “Delta is a game-changer (pun intended). This variant is hyper-infectious and...

David Weber, MD, MPH, professor of medicine in the division of infectious diseases, commented on UV light technology, which is used in the LARQ Bottle. The new bottle was designed to give people around the world access to pristine drinking water, easily and sustainably. A news report in King Weekly Sentinel reports...

Dr. Anthony Fauci, America’s top infectious disease expert, said he believes booster shots will be available for Americans starting Sept. 20 – but not everyone will be able to get a dose right away. David Wohl, MD, professor of medicine in the division of infectious diseases, answered questions about booster...

WRAL reports that evidence is mounting to show the fight against COVID-19 in North Carolina could be about to enter uncharted waters. “We’re in the place we are now, a place of surge, a place of pain, a place of chaos, because, to be truthful, we have so many people...

The National Institute on Aging has awarded Shakira Grant, MBBS, and the ºÚÁÏÍø Center for Aging and Health a 2-year, $200,000 grant to study the illness and treatment experiences and functional trajectories of older adults with multiple myeloma and their care partners. Grant is assistant professor in the divisions of...

Principal investigators James Hagood, MD, professor of pediatrics and Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine in the division of pulmonary diseases and critical care medicine will lead a multinational, $3.5-million project funded through the Chan Zuckerberg Initiative to map crucial cellular roles in human health and...

David Wohl, MD, professor of medicine in the division of infectious diseases, talked with ABC-11 about COVID-19 models and when cases might peak. He also answered questions about vaccines for kids and booster shots for adults. Watch the news story.